Yuko Takezawa

Discovery of a Structurally Novel Opioid .KAPPA.-Agonist Derived from 4,5-Epoxymorphinan.

Hiroshi Nagase, Jun Hayakawa, Kuniaki Kawamura et al. · Chemical and Pharmaceutical Bulletin · 1998 · 187 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +12

Rational Drug Design and Synthesis of a Highly Selective Nonpeptide .DELTA.-Opioid Agonist, (4aS*,12aR*)-4a-(3-Hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine (TAN-67).

Hiroshi Nagase, Koji Kawai, Jun Hayakawa et al. · Chemical and Pharmaceutical Bulletin · 1998 · 72 citations · Full text

Selective Non-peptide Agonists, Peptide Science, Pharmacotherapy +19

Effect of repeated administration of TRK-820, a κ-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions

Tomohiko Suzuki, Naoki Izumimoto, Yuko Takezawa et al. · Brain Research · 2003 · 37 citations

κ-Opioid Receptor Agonist, Molecular Pharmacology, Pain Therapy +13

Syntheses of Non-Peptidic Delta Opioid Agonists and Their Structure Activity Relationships.

Hiroshi Nagase, Hisanori Wakita, Koji Kawai et al. · The Japanese Journal of Pharmacology · 1994 · 26 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +9